A multi-biomarker disease activity score can predict sustained remission in rheumatoid arthritis

BACKGROUND: Reliable assessment of remission is important for the optimal management of rheumatoid arthritis (RA) patients. In this study, we used the multi-biomarker disease activity (MBDA) test to explore the role of biomarkers in predicting point remission and sustained remission. METHODS: RA pat...

Descripción completa

Detalles Bibliográficos
Autores principales: Ma, M. H. Y., Defranoux, N., Li, W., Sasso, E. H., Ibrahim, F., Scott, D. L., Cope, A. P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7313155/
https://www.ncbi.nlm.nih.gov/pubmed/32580789
http://dx.doi.org/10.1186/s13075-020-02240-w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7313155/
https://www.ncbi.nlm.nih.gov/pubmed/32580789
http://dx.doi.org/10.1186/s13075-020-02240-w

Ejemplares similares